Why Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Could Be Worth WatchingHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Why Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Could Be Worth WatchingSimply Wall StSimply Wall St.January 3, 2020ReblogShareTweetShareView photosAllscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), which is in the healthcare services business, and is based in United States, saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$11.59 and falling to the lows of US$9.40. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Allscripts Healthcare Solutions's current trading price of US$9.69 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Allscripts Healthcare Solutions’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change. Check out our latest analysis for Allscripts Healthcare Solutions What is Allscripts Healthcare Solutions worth?Good news, investors! Allscripts Healthcare Solutions is still a bargain right now. According to my valuation, the intrinsic value for the stock is $14.93, but it is currently trading at US$9.69 on the share market, meaning that there is still an opportunity to buy now. Although, there may be another chance to buy again in the future. This is because Allscripts Healthcare Solutions’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.What does the future of Allscripts Healthcare Solutions look like?NasdaqGS:MDRX Past and Future Earnings, January 3rd 2020MoreInvestors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 86% over the next year, the near-term future seems bright for Allscripts Healthcare Solutions. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.What this means for you:Are you a shareholder? Since MDRX is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.Are you a potential investor? If you’ve been keeping an eye on MDRX for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy MDRX. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Allscripts Healthcare Solutions. You can find everything you need to know about Allscripts Healthcare Solutions in the latest infographic research report. If you are no longer interested in Allscripts Healthcare Solutions, you can use our free platform to see my list of over 50 other stocks with a high growth potential.Story continuesIf you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoHere are 5 reasons the stock market is having its worst decline since 2008, and only one of them is the coronavirusMarketWatchMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoOil’s Worst Week Since 2014 Puts Pressure on OPEC+ to RespondBloombergStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceMarket Recap: Friday, Dec. 13Yahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance